• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型手性 2-甲基-5,6,7,8-四氢喹啉-8-胺类化合物的生物学性质。

Biological Properties of New Chiral 2-Methyl-5,6,7,8-tetrahydroquinolin-8-amine-based Compounds.

机构信息

DISFARM, Sezione di Chimica Generale e Organica "A. Marchesini", Università degli Studi di Milano via Venezian, 21, 20133 Milano, Italy.

Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, via F. Marzolo, 5, 35131 Padova, Italy.

出版信息

Molecules. 2020 Nov 27;25(23):5561. doi: 10.3390/molecules25235561.

DOI:10.3390/molecules25235561
PMID:33260896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7729733/
Abstract

The synthesis of a small library of 8-substituted 2-methyl-5,6,7,8-tetrahydroquinoline derivatives is presented. All the compounds were tested for their antiproliferative activity in non-cancer human dermal microvascular endothelial cells (HMEC-1) and cancer cells: human T-lymphocyte cells (CEM), human cervix carcinoma cells (HeLa), human dermal microvascular endothelial cells (HMEC-1), colorectal adenocarcinoma (HT-29), ovarian carcinoma (A2780), and biphasic mesothelioma (MSTO-211H). Compounds , , and , showing significant IC values against the whole panel of the selected cells, were further synthesized and tested as pure enantiomers in order to shed light on how their stereochemistry might impact on the related biological effect. The most active compound was able to affect cell cycle phases and to induce mitochondrial membrane depolarization and cellular ROS production in A2780 cells.

摘要

本文介绍了 8-取代 2-甲基-5,6,7,8-四氢喹啉衍生物的小库合成。所有化合物均在非癌人类真皮微血管内皮细胞(HMEC-1)和癌细胞中进行了抗增殖活性测试:人 T 淋巴细胞(CEM)、人宫颈癌细胞(HeLa)、人真皮微血管内皮细胞(HMEC-1)、结肠直肠腺癌(HT-29)、卵巢癌细胞(A2780)和双相间皮瘤(MSTO-211H)。化合物 、 、 和 对所选细胞的整个细胞系表现出显著的 IC 值,进一步合成并作为纯对映异构体进行测试,以阐明其立体化学如何影响相关的生物学效应。最活性化合物 能够影响 A2780 细胞的细胞周期阶段,并诱导线粒体膜去极化和细胞 ROS 产生。

相似文献

1
Biological Properties of New Chiral 2-Methyl-5,6,7,8-tetrahydroquinolin-8-amine-based Compounds.新型手性 2-甲基-5,6,7,8-四氢喹啉-8-胺类化合物的生物学性质。
Molecules. 2020 Nov 27;25(23):5561. doi: 10.3390/molecules25235561.
2
Platinum(ii) complexes showing high cytotoxicity toward A2780 ovarian carcinoma cells.表现出对 A2780 卵巢癌细胞高细胞毒性的铂(ii)配合物。
Dalton Trans. 2019 Sep 14;48(34):13081-13093. doi: 10.1039/c9dt02894c. Epub 2019 Aug 14.
3
Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.新型噻唑取代双吡唑啉肟衍生物的设计、合成及通过选择性诱导癌细胞凋亡和 ROS 产生的抗肿瘤活性的生物评价。
Med Chem. 2019;15(7):743-754. doi: 10.2174/1573406414666180827112724.
4
Novel pyrazolo[3,4-d]pyrimidine derivatives inhibit human cancer cell proliferation and induce apoptosis by ROS generation.新型吡唑并[3,4-d]嘧啶衍生物通过 ROS 生成抑制人癌细胞增殖并诱导细胞凋亡。
Arch Pharm (Weinheim). 2020 Apr;353(4):e1900296. doi: 10.1002/ardp.201900296. Epub 2020 Feb 19.
5
Synthesis of new hetero-arylidene-9(10H)-anthrone derivatives and their biological evaluation.新型杂芳亚甲基-9(10H)-蒽酮衍生物的合成及其生物评价。
Bioorg Chem. 2020 Jun;99:103849. doi: 10.1016/j.bioorg.2020.103849. Epub 2020 Apr 14.
6
Biological Evaluation of Ferrocenyl Olefins: Cancer Cell Growth Inhibition, ROS Production, and Apoptosis Activity.二茂铁基烯烃的生物学评价:癌细胞生长抑制、活性氧生成及凋亡活性
Arch Pharm (Weinheim). 2016 Mar;349(3):186-92. doi: 10.1002/ardp.201500314. Epub 2016 Feb 3.
7
A cancer specific oxaliplatin-releasing Pt(iv)-prodrug.一种针对癌症的奥沙利铂释放型 Pt(iv)-前药。
Dalton Trans. 2018 May 15;47(19):6679-6682. doi: 10.1039/c8dt01458b.
8
Zn(II) and Co(II) derivatives anchored with scorpionate precursor: Antiproliferative evaluation in human cancer cell lines.Zn(II) 和 Co(II) 衍生物与拟蝎配体前体配位:对人癌细胞系的抗增殖评价。
J Inorg Biochem. 2020 Jan;202:110881. doi: 10.1016/j.jinorgbio.2019.110881. Epub 2019 Oct 23.
9
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents.设计、合成及生物评价 3-取代-2-氧代吲哚杂合衍生物作为新型抗癌剂。
Eur J Med Chem. 2017 Jul 7;134:258-270. doi: 10.1016/j.ejmech.2017.03.089. Epub 2017 Apr 13.
10
Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.探讨新型菲咯啉水杨醛亚胺锌(II)配合物的细胞毒性活性。
J Inorg Biochem. 2019 Sep;198:110727. doi: 10.1016/j.jinorgbio.2019.110727. Epub 2019 Jun 1.

引用本文的文献

1
Analogues of Anticancer Natural Products: Chiral Aspects.抗癌天然产物类似物:手性方面。
Int J Mol Sci. 2023 Mar 16;24(6):5679. doi: 10.3390/ijms24065679.
2
Chiral 8-Amino-5,6,7,8-tetrahydroquinoline Derivatives in Metal Catalysts for the Asymmetric Transfer Hydrogenation of 1-Aryl Substituted-3,4-dihydroisoquinolines as Alkaloids Precursors.手性 8-氨基-5,6,7,8-四氢喹啉衍生物在金属催化剂中的应用:不对称转移氢化 1-芳基取代-3,4-二氢异喹啉作为生物碱前体。
Molecules. 2023 Feb 16;28(4):1907. doi: 10.3390/molecules28041907.

本文引用的文献

1
Synthesis, Antiproliferative Effect, and Topoisomerase II Inhibitory Activity of 3-Methyl-2-phenyl-1-indoles.3-甲基-2-苯基-1-吲哚的合成、抗增殖作用及拓扑异构酶II抑制活性
ACS Med Chem Lett. 2020 Jan 24;11(5):691-697. doi: 10.1021/acsmedchemlett.9b00557. eCollection 2020 May 14.
2
The Exploration of Chirality for Improved Druggability within the Human Kinome.手性在人类激酶组中提高成药性的探索。
J Med Chem. 2020 Jan 23;63(2):441-469. doi: 10.1021/acs.jmedchem.9b00640. Epub 2019 Oct 9.
3
Primaquine derivatives: Modifications of the terminal amino group.
原氨喹衍生物:末端氨基基团的修饰。
Eur J Med Chem. 2019 Nov 15;182:111640. doi: 10.1016/j.ejmech.2019.111640. Epub 2019 Aug 23.
4
Anticancer platinum(II) complexes bearing N-heterocycle rings.含氮杂环的抗癌铂(II)配合物。
Bioorg Med Chem Lett. 2019 Jun 1;29(11):1257-1263. doi: 10.1016/j.bmcl.2019.03.045. Epub 2019 Mar 29.
5
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents.新型呋喃基水杨酸合酶(MbtI)抑制剂结构-活性关系研究进展及其作为潜在抗结核药物的潜力。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):823-828. doi: 10.1080/14756366.2019.1589462.
6
Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor.四氢异喹啉 CXCR4 拮抗剂在 CXCR4 受体的肽亚口袋内采用混合结合模式。
ACS Med Chem Lett. 2018 Nov 30;10(1):67-73. doi: 10.1021/acsmedchemlett.8b00441. eCollection 2019 Jan 10.
7
Enantioselective Drug Recognition by Drug Transporters.手性药物识别的药物转运体。
Molecules. 2018 Nov 22;23(12):3062. doi: 10.3390/molecules23123062.
8
Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma.靶向DNA结合的核因子κB作为肝细胞癌的一种抗癌方法
Cells. 2018 Oct 22;7(10):177. doi: 10.3390/cells7100177.
9
Synthesis and mechanistic studies of quinolin-chlorobenzothioate derivatives with proteasome inhibitory activity in pancreatic cancer cell lines.具有蛋白酶体抑制活性的喹啉-氯苯并噻吩酯衍生物的合成及机制研究。
Eur J Med Chem. 2018 Oct 5;158:884-895. doi: 10.1016/j.ejmech.2018.09.037. Epub 2018 Sep 15.
10
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.新型水杨酸合酶(MbtI)呋喃抑制剂的发现和开发作为抗结核药物。
Eur J Med Chem. 2018 Jul 15;155:754-763. doi: 10.1016/j.ejmech.2018.06.033. Epub 2018 Jun 18.